"XAir Diagnostics B.V. - Product Pipeline Analysis." Now Available at Fast Market Research
XAir Diagnostics B.V. (XAir) develops diagnostics based on the exhaled breath for diseases with large unmet diagnostic needs. The company is developing diagnostic products and services with clear benefits to patients and physicians, by analysing the exhaledbreath of patients. XAir developed a proprietary discovery platform XVOC whioch allows to identify volatile organic compounds (VOC) sets which correlate with a number of diseases with the high sensitivity (>90%) and specificity (>90%). It is developing assays for progression of the diseases and...
View full press release